Inhibitor Therapeutics, Inc. (INTI) Insider Trading -- Recent Executive & Director Transactions
9 insiders reported 9 Form 4 transactions for Inhibitor Therapeutics, Inc. (INTI) over the past 18 months (most recent 2026-08-04). Recent activity: ODONNELL FRANCIS E JR (Chief Executive Officer) Buy 50,000 shares, SEARS SAMUEL P JR (Director) Buy 50,000 shares, MCNULTY JAMES A (Chief Financial Officer) Sell 3.2M shares, OSMAN RONALD E (Director) Buy 50,000 shares, Yanez Michelle (Director) Buy 50,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-04 | ODONNELL FRANCIS E JR | Chief Executive Officer | Buy | 50,000 | $0 |
| 2026-08-04 | SEARS SAMUEL P JR | Director | Buy | 50,000 | $0 |
| 2026-08-04 | MCNULTY JAMES A | Chief Financial Officer | Sell | 3.2M | $0 |
| 2026-08-04 | OSMAN RONALD E | Director | Buy | 50,000 | $0 |
| 2026-08-04 | Yanez Michelle | Director | Buy | 50,000 | $0 |
| 2026-08-04 | Ronald E. Osman Irrevocable Trust III under Agreement dated May 13, 2012 | 10% Owner | Buy | 50,000 | $0 |
| 2026-08-04 | Black Robe Capital LLC | 10% Owner | Sell | 3.2M | $0 |
| 2026-06-24 | Jerman Michael Allen | Director | Buy | 50,000 | $0 |
| 2026-06-01 | Vasisht Niraj | Director | Buy | 50,000 | $0 |
Source: SEC Form 4 filings · as of 2026-08-04